Business Context and Reporting Period
This Form 8-K is filed by Big Rock Partners Acquisition Corp. (not NRX Pharmaceuticals, Inc.) on July 17, 2019. The registrant is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware and listed on the NASDAQ. The report details an extension of the deadline to consummate an initial business combination.
Key Financial Metrics and Obligations
- Extension Payment: The Company deposited $95,604.56 into its trust account on July 17, 2019, representing the third extension payment.
- Debt Issuance: To fund part of the extension payment, the Company issued an unsecured promissory note in the principal amount of $6,813.68.
- Lender: The note was issued to BRAC Lending Group LLC, an entity affiliated with EarlyBirdCapital, Inc.
- Interest Rate: The note does not bear interest.
- Liquidity: The filing does not provide a clear value for total cash, working capital, or overall liquidity outside of the specific trust deposit and note issuance.
Material Changes
The primary material change is the extension of the Termination Date for consummating an initial business combination to August 22, 2019. This follows previous extensions on May 21, 2019, and June 20, 2019. The Company has now utilized three extension periods, with $0.02 per public share deposited for each period.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company must complete a business combination by August 22, 2019, unless stockholders approve a further amendment.
- Debt Forgiveness Contingency: If the Company fails to consummate a business combination, the outstanding debt under the promissory note will be forgiven, except to the extent of any funds held outside the trust account after paying all other fees and expenses.
- Management Commentary: The filing confirms the execution of the extension mechanism as previously disclosed but provides no additional strategic commentary or guidance on potential targets.
Investor Verification Checklist
- Verify the total number of public shares outstanding to confirm the $0.02 per share calculation matches the $95,604.56 deposit.
- Confirm the status of the trust account balance following the July 17 deposit.
- Review the Company's ability to secure a business combination before the August 22, 2019 deadline.
- Assess the potential impact of the $6,813.68 note on the Company's non-trust assets if a liquidation occurs.